Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-trace').style.display = (document.getElementById('cakeErr67f9644c86051-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f9644c86051-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-code').style.display = (document.getElementById('cakeErr67f9644c86051-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-context').style.display = (document.getElementById('cakeErr67f9644c86051-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f9644c86051-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f9644c86051-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 59128,
		&#039;title&#039; =&gt; &#039;How India landed in Covid vaccine mess - GS Mudur  &#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;how-india-landed-in-covid-vaccine-mess-gs-mudur&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 59128,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  &#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot; title=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 59128,
	&#039;title&#039; =&gt; &#039;How India landed in Covid vaccine mess - GS Mudur  &#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;how-india-landed-in-covid-vaccine-mess-gs-mudur&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 59128
$metaTitle = &#039;LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  &#039;
$metaKeywords = &#039;Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production&#039;
$metaDesc = &#039;-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot; title=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur   | Im4change.org</title>
    <meta name="description" content="-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>How India landed in Covid vaccine mess - GS Mudur  </strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p><p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p><p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p><p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p><p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p><p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p><p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p><p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p><p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p><p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p><p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969" title="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-trace').style.display = (document.getElementById('cakeErr67f9644c86051-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f9644c86051-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-code').style.display = (document.getElementById('cakeErr67f9644c86051-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-context').style.display = (document.getElementById('cakeErr67f9644c86051-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f9644c86051-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f9644c86051-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 59128,
		&#039;title&#039; =&gt; &#039;How India landed in Covid vaccine mess - GS Mudur  &#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;how-india-landed-in-covid-vaccine-mess-gs-mudur&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 59128,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  &#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot; title=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 59128,
	&#039;title&#039; =&gt; &#039;How India landed in Covid vaccine mess - GS Mudur  &#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;how-india-landed-in-covid-vaccine-mess-gs-mudur&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 59128
$metaTitle = &#039;LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  &#039;
$metaKeywords = &#039;Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production&#039;
$metaDesc = &#039;-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot; title=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur   | Im4change.org</title>
    <meta name="description" content="-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>How India landed in Covid vaccine mess - GS Mudur  </strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p><p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p><p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p><p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p><p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p><p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p><p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p><p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p><p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p><p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p><p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969" title="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-trace').style.display = (document.getElementById('cakeErr67f9644c86051-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f9644c86051-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-code').style.display = (document.getElementById('cakeErr67f9644c86051-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f9644c86051-context').style.display = (document.getElementById('cakeErr67f9644c86051-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f9644c86051-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f9644c86051-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 59128,
		&#039;title&#039; =&gt; &#039;How India landed in Covid vaccine mess - GS Mudur  &#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;how-india-landed-in-covid-vaccine-mess-gs-mudur&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 59128,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  &#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot; title=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 59128,
	&#039;title&#039; =&gt; &#039;How India landed in Covid vaccine mess - GS Mudur  &#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;how-india-landed-in-covid-vaccine-mess-gs-mudur&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 59128
$metaTitle = &#039;LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  &#039;
$metaKeywords = &#039;Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production&#039;
$metaDesc = &#039;-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;India&amp;rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&amp;rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The experts, who have tracked global vaccine efforts, said the Indian government&amp;rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&amp;rsquo;s department of biotechnology, for Covid-19 vaccines.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;An epidemiologist who asked not to be named described this as a &amp;ldquo;botch-up&amp;rdquo;.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;img alt=&quot;&quot; src=&quot;/upload/images/Vaccine%20covid.jpg&quot; style=&quot;height:1000px; width:621px&quot; /&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&amp;rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;The department of biotechnology had on April 16 &amp;mdash; three months after the launch of India&amp;rsquo;s vaccination campaign &amp;mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &amp;ldquo;finite&amp;rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot; title=&quot;https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969&quot;&gt;click here&lt;/a&gt; to read more.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/how-india-landed-in-covid-vaccine-mess-gs-mudur.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur   | Im4change.org</title>
    <meta name="description" content="-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>How India landed in Covid vaccine mess - GS Mudur  </strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p><p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p><p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p><p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p><p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p><p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p><p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p><p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p><p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p><p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p><p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969" title="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 59128,
		'title' => 'How India landed in Covid vaccine mess - GS Mudur  ',
		'subheading' => null,
		'description' => '<p style="text-align:justify">-The Telegraph</p>

<p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p>

<p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p>

<p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p>

<p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p>

<p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p>

<p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p>

<p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p>

<p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p>

<p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p>

<p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p>

<p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p>

<p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>
',
		'credit_writer' => 'The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'how-india-landed-in-covid-vaccine-mess-gs-mudur',
		'meta_title' => '',
		'meta_keywords' => '',
		'meta_description' => '',
		'noindex' => (int) 1,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => null,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 59128,
	'metaTitle' => 'LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  ',
	'metaKeywords' => 'Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production',
	'metaDesc' => '-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s...',
	'disp' => '<p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p><p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p><p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p><p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p><p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p><p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p><p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p><p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p><p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p><p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p><p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969" title="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 59128,
	'title' => 'How India landed in Covid vaccine mess - GS Mudur  ',
	'subheading' => null,
	'description' => '<p style="text-align:justify">-The Telegraph</p>

<p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p>

<p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p>

<p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p>

<p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p>

<p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p>

<p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p>

<p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p>

<p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p>

<p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p>

<p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p>

<p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p>

<p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>
',
	'credit_writer' => 'The Telegraph, 19 April, 2021, https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'how-india-landed-in-covid-vaccine-mess-gs-mudur',
	'meta_title' => '',
	'meta_keywords' => '',
	'meta_description' => '',
	'noindex' => (int) 1,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => null,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 59128
$metaTitle = 'LATEST NEWS UPDATES | How India landed in Covid vaccine mess - GS Mudur  '
$metaKeywords = 'Coronavirus,Covaxin,Covid-19,Covid-19 Vaccination,Covid-19 Vaccines,Covishield,Vaccine Production'
$metaDesc = '-The Telegraph

The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin

India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s...'
$disp = '<p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin</em></p><p style="text-align:justify">India&rsquo;s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government&rsquo;s lack of funding for key vaccines under development and evaluation, experts have said.</p><p style="text-align:justify">The experts, who have tracked global vaccine efforts, said the Indian government&rsquo;s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them.</p><p style="text-align:justify">The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry&rsquo;s department of biotechnology, for Covid-19 vaccines.</p><p style="text-align:justify">But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.</p><p style="text-align:justify">An epidemiologist who asked not to be named described this as a &ldquo;botch-up&rdquo;.</p><p style="text-align:justify">The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources.</p><p style="text-align:justify"><img alt="" src="/upload/images/Vaccine%20covid.jpg" style="height:1000px; width:621px" /></p><p style="text-align:justify">The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech&rsquo;s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research.</p><p style="text-align:justify">The department of biotechnology had on April 16 &mdash; three months after the launch of India&rsquo;s vaccination campaign &mdash; announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September.</p><p style="text-align:justify">Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the &ldquo;finite&rdquo; supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969" title="https://www.telegraphindia.com/india/how-we-landed-in-covid-vaccine-mess/cid/1812969">click here</a> to read more.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

How India landed in Covid vaccine mess - GS Mudur

-The Telegraph The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them. The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry’s department of biotechnology, for Covid-19 vaccines. But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development. An epidemiologist who asked not to be named described this as a “botch-up”. The Serum Institute invested $270 million (Rs 2,012 crore) of its money and $300 million (Rs 2,236 crore) from the Bill and Melinda Gates Foundation to build production capacity for its vaccines, while Bharat Biotech relied almost entirely on its internal resources. The Centre covered the costs of the Covishield clinical trials by the Serum Institute and supported Bharat Biotech’s efforts through laboratory research and animal studies at the National Institute of Virology in Pune, an arm of the Indian Council of Medical Research. The department of biotechnology had on April 16 — three months after the launch of India’s vaccination campaign — announced it would provide Rs 65 crore to Bharat Biotech to increase production from the current 10 million to 100 million doses of Covaxin per month by September 2021. It also pledged funds to three public sector units to produce an additional 35 million doses per month by September. Covid-19 vaccines are currently being offered in India only to people 45 years or older. Health officials have underlined the “finite” supply to argue against suggestions that the campaign be widened to cover younger adults, at least in the areas hit the hardest by the pandemic. Please click here to read more.